Image

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers.

The main question is:

• to discover the factors associated with quality of life and stress in patient-caregiver dyads.

Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data.

Researchers will compare a group of participants without stroke to establish a comparable baseline.

Description

Introduction/Background

In Switzerland, approximately 21,000 people suffer a stroke each year. Stroke causes neurological impairments for those affected and brings about a sudden change in their life situation. The relatives of stroke patients receive new social roles and are challenged in a new way by the morbidity of the affected person, leading to a change in their quality of life and aggravation of stress. Unlike chronic diseases, a stroke occurs suddenly, so relatives have no opportunity to gradually adapt to the new living circumstances or to deal with the new psychosocial roles and demands beforehand. To what extent the daily life of patients and their relatives changes and what impact this has on their quality of life and stress has not been systematically investigated in Switzerland thus far.

Aims and significance of the project

The aim of the project is to systematically assess the quality of life and stress, as well as to capture stress biomarkers in stroke patients and their relatives. The investigators plan to conduct sequential measurements of quality of life and stress hormones at multiple time points over 12 months. The goal is in particular to uncover the relationships between the extent of patients' impairments, their quality of life, and stress in affected individuals and their relatives. This is a first-time project with the goal of learning more about stressors and biological relationships. This will create the basis for a multimodal intervention to improve the quality of life of those affected and their relatives, which will be investigated in a follow-up project.

Methods

The Investigators plan a prospective study with a survey of stroke patients and their relatives regarding their quality of life in everyday life. It will also be examined, how multiple stress biomarkers (which will be determined in blood and hair) are related to quality of life and stress and which clinical factors have a positive and negative influence on the well-being of patients and their relatives.

Eligibility

Control group:

Inclusion criteria:

  • over 18 years old
  • No previous stroke OR previous stroke >3 years ago
  • No significant disability (maximum mRS 1)
  • ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology
  • Patients' AND caregiver's ability to give informed consent
  • Patients' AND close relative's / caregiver's willingness to participate

Exclusion criteria:

        • Medication with steroid hormones (prednisone, prednisolone, dexamethasone,
        methylprednisolone, hydrocortisone etc.) within last 3 months
        Main Group:
        Inclusion criteria:
          -  over 18 years old
          -  Patients diagnosed with either transient ischemic attack, ischemic stroke or
             intracerebral hemorrhage and their caregivers
          -  Caregiver of a patient as described above, age over 18 years
          -  Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ)
             included within 28 days from event.
          -  Patients' AND caregiver's ability to give informed consent
          -  Patients' AND caregiver's willingness to participate
        Exclusion criteria:
        • Medication with steroid hormones (prednisone, prednisolone, dexamethasone,
        methylprednisolone, hydrocortisone etc.) within last 3 months

Study details

Quality of Life, Stroke, Acute, Sexual Behavior, Stress

NCT06443268

University of Zurich

11 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.